Malta - Engels - Medicines Authority

synthon bv microweg 22, 6545 cm nijmegen, netherlands - clozapine - orodispersible tablet - clozapine 25 mg - psycholeptics

Malta - Engels - Medicines Authority

novartis pharmaceuticals uk limited frimley business park, frimley camberley, surrey gu16 7sr, united kingdom - clozapine - tablet - clozapine 25 mg - psycholeptics

Australië - Engels - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - clozapine, quantity: 25 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; colloidal anhydrous silica; povidone; magnesium stearate; purified talc - clozaril is indicated in treatment-resistant schizophrenic patients only, ie. schizophrenic patients who are non-responsive to, or intolerant of other antipsychotic drugs. non-responsiveness is defined as a lack of satisfactory clinical improvement despite the use of adequate doses of at least two classes of marketed antipsychotic drugs prescribed for reasonable durations. intolerance is defined as the impossibility to achieve adequate benefit with other antipsychotic drugs because of severe and untreatable neurological adverse reactions (extrapyramidal side effects or tardive dyskinesia).

Australië - Engels - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - clozapine, quantity: 200 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; povidone; purified talc; colloidal anhydrous silica; magnesium stearate

Australië - Engels - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - clozapine, quantity: 100 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; povidone; purified talc; colloidal anhydrous silica; magnesium stearate

Australië - Engels - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - clozapine, quantity: 50 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; povidone; purified talc; colloidal anhydrous silica; magnesium stearate

Australië - Engels - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - clozapine, quantity: 25 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; colloidal anhydrous silica; povidone; magnesium stearate; purified talc - clozapine mylan is indicated in treatment-resistant schizophrenic patients only, ie. schizophrenic patients who are non-responsive to, or intolerant of other antipsychotic drugs. non-responsiveness is defined as a lack of satisfactory clinical improvement despite the use of adequate doses of at least two classes of marketed antipsychotic drugs prescribed for reasonable durations. intolerance is defined as the impossibility to achieve adequate benefit with other antipsychotic drugs because of severe and untreatable neurological adverse reactions (extrapyramidal side effects or tardive dyskinesia).

Australië - Engels - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - clozapine, quantity: 100 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; maize starch; purified talc; magnesium stearate; povidone - clozapine mylan is indicated in treatment-resistant schizophrenic patients only, i.e. schizophrenic patients who are non-responsive to, or intolerant of other antipsychotic drugs. non-responsiveness is defined as a lack of satisfactory clinical improvement despite the use of adequate doses of at least two classes of marketed antipsychotic drugs prescribed for reasonable durations. intolerance is defined as the impossibility to achieve adequate benefit with other antipsychotic drugs because of severe and untreatable neurological adverse reactions (extrapyramidal side effects or tardive dyskinesia).

Israël - Engels - Ministry of Health

taro international ltd, israel - clozapine - tablets - clozapine 100 mg - clozapine - clozapine - treatment of resistant schizophrenic patients who are non-responsive to, or intolerant of classic neuroleptics.reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state.suicidal behavior refers to actions by a patient that put him/herself at risk for death

Verenigd Koninkrijk - Engels - MHRA (Medicines & Healthcare Products Regulatory Agency)

leyden delta b.v. - clozapine - oral tablet - 25mg